CLINICAL_TRIALS
trial_result
· 2017-02-27
Clinical Trial Update: First Human Dose Trial of NNC0215-0384 in Subjects With Rheumatoid Arthritis [Phase 1]
Summary
This update reports a first-in-human, Phase 1 trial of NNC0215-0384 in subjects with rheumatoid arthritis, which has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novo Nordisk A/S | Conditions: Inflammation, Rheumatoid Arthritis | Phase 1 | Status: COMPLETED